UTMDNasdaqSurgical & Medical Instruments & Apparatus

Utah Medical Products Inc (UTMD) earnings date, market-implied expected move, and options open interest by expiry

72.28

+2.26 · +3.23%

Regular session13:42 ET

Open72.30Volume29,553Mkt cap$222.9MP/E22.04EPS3.28Div yield1.77%

Day72.28 – 72.300%52-wk52.65 – 76.8981%

UTMD

Utah Medical Products Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Jan 28

in 85 days

est.Q4 FY26

Calendar

Next report

Last report

+0.46%

shaded = implied · ▲▼ = realized

Oct 22 '26 · confirmed

Implied vs realized

Largest filed tie

1.00%

of UTMD revenue · PendoTECH

customerUTMD 10-K

Largest filed tie

13F top-10 QoQ

+2.47%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

114 managers

Top fund weight

0.01%

UTMD weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Utah Medical Products (UTMD) is expected to report on Jan 28 (estimated date).

Implied vs realized

8 reports

—≥ implied

Jan 28 '25Jan 28 '25confirmed—▼−1.82%—

Apr 29 '25Apr 29 '25confirmed—▲+0.56%—

Q2 FY25Jul 24 '25confirmed—▼−0.21%—

Oct 23 '25Oct 23 '25confirmed—▼−0.93%—

Jan 29 '26Jan 29 '26confirmed—▲+1.33%—

Q1 FY26Apr 23 '26confirmed—▼−2.53%—

Q2 FY26Jul 23 '26confirmed—▼−7.24%—

Oct 22 '26Oct 22 '26confirmed—▲+0.46%—

quarterimplied−10%0+10%realized×

Oct '26—▲+0.46%—

Q2 FY26—▼−7.24%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

No open-interest data.

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

31.49%as filednet margin · revenue −2.21% QoQ · −14.31% YoY

Revenue

$9M−2.21% QoQ

Gross profit

$5M−9.92% QoQ

55.79% margin

Operating income

$3M+3.27% QoQ

31.06% margin

Pre-tax income

$3M+3.27% QoQ

Net income

$3M+3.15% QoQ

31.49% margin

Cost of revenue

$4M+9.62% QoQ

Operating expenses

$2M−22.38% QoQ

SG&A $2M

R&D $154,000

Tax

$600,000+3.81% QoQ

Other income

$637,000+3.24% QoQ

Revenue$9M−2.21%

Gross profit

$5M−9.92%

55.79% margin

Operating income

$3M+3.27%

31.06% margin

Pre-tax income

$3M+3.27%

Net income

$3M+3.15%

31.49% margin

Cost of revenue

$4M+9.62%

Operating expenses

$2M−22.38%

SG&A $2M

R&D $154,000

Other income$637,000+3.24%

Tax$600,000+3.81%

flow · deduction · inflow · signed % = QoQSource: SEC filings · standardized · QE Jun 30 '26 · width = $

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 13:30 ET

Intraday

Event sensitivity

FOMC ×1.17· ±1.3% vs ±1.1% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±1.3%8 of 24×1.17

Quarter	Reported	EPS	Consensus
Q2 FY26	Jul 23 '26 · confirmed	0.84	—
Q1 FY26	Apr 23 '26 · confirmed	0.82	—
Q2 FY25	Jul 24 '25 · confirmed	0.94	—

Utah Medical Products Inc (UTMD) earnings date, market-implied expected move, and options open interest by expiry

Implied vs realized

Implied vs realized

Positioning

Positioning

Linked exposure

Linked exposure

Revenue flow

Revenue flow

Intraday

Intraday

Event sensitivity

Implied vs realized

Event sensitivity

Earnings history

Methodology

Positioning

Linked exposure

Intraday

Revenue flow

Utah Medical Products Inc (UTMD) earnings date, market-implied expected move, and options open interest by expiry